Meeting
2011 ASCO Annual Meeting
Incidence of anthracycline-induced cardiotoxicity in patients with breast cancer: A single center's experience.
Authors
O. Nadeem
Dartmouth-Hitchcock Medical Center, Lebanon, NH
O. Nadeem , C. Rauwerdink , V. L. Beggs , D. D. Parr , A. T. Kono , G. N. Schwartz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer - Triple-negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Cytotoxic Chemotherapy
Citation
J Clin Oncol 29: 2011 (suppl; abstr 1093)
Abstract #
1093
Poster Bd #
21B
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Cardiac safety and efficacy for patients with early-stage breast cancer treated with pegylated liposomal doxorubicin (PLD) or doxorubicin.
First Author: Lichen Tang
Poster
2015 Breast Cancer Symposium
Trastuzumab-induced cardiotoxicity in Uruguayan HER2-positive breast cancer patients.
First Author: Andrea Schiavone
Poster
2023 ASCO Breakthrough
Risk factors and predictors of tumor recurrence among breast cancer patients in a tertiary government hospital in the Philippines.
First Author: Omar Paningbatan Maaño
Poster
2022 ASCO Quality Care Symposium
Measuring risk factors and incidence of cardiotoxicity and integrative therapy utilization in South Asian women with breast cancer: A single institution experience.
First Author: Rushil Virendra Patel